Steward Partners Investment Advisory, LLC Recursion Pharmaceuticals, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $9.37 Billion
- Q2 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 1,583 shares of RXRX stock, worth $10,938. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,583
Previous 583
171.53%
Holding current value
$10,938
Previous $5,000
120.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RXRX
# of Institutions
285Shares Held
236MCall Options Held
972KPut Options Held
2.4M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl28.1MShares$194 Million1.92% of portfolio
-
Baillie Gifford & CO26.6MShares$184 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$149 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$120 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$106 Million1.74% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.25B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...